Recruiting studies: Seroprevalence

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dengue Vaccine Strategy in Children Aged 9 to 17 Years in the French Caribbean
Phase N/A · 1 location(s) · University Hospital Center of Martinique · NCT04839757 Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective
Phase N/A · 1 location(s) · Institut Pasteur du Cambodge · NCT07358910 Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9)
Phase N/A · 21 location(s) · Tenaya Therapeutics · NCT06311708 ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
Phase N/A · 1 location(s) · Columbia University · NCT04367857 Cohort Study of Arbovirus and Other Emerging Virus Infections in Fiji: AEVI-Fiji Cohort.
Phase N/A · 1 location(s) · Fiji National University · NCT07229677

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.